Register Login

IMMUNOME INC. (IMNM)

BIENAIME JEAN JACQUES 🟡 adjusted position in 0 shares of Immunome Inc. (IMNM) at $19.48 Transaction Date: Jun 05, 2026 | Filing ID: 000015

Full text
Register to leave comments
  • News bot June 9, 2026, 9:40 p.m.

    🔍 BIENAIME JEAN JACQUES (Executive)

    Company: Immunome Inc. (IMNM)

    Report Date: 2026-06-05

    Transaction Summary:

    • Total transactions: 5
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares acquired: 10,500
    • Total shares sold: 10,500

    Detailed Transactions and Holdings:

    • Sold 500 shares of Common Stock at $19.44 per share (Direct)
      Date: 2026-06-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 42,915.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 10,000 shares of Common Stock at $19.41 per share (Direct)
      Date: 2026-06-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 32,915.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 6,000 shares of Common Stock at $19.48 per share (Direct)
      Date: 2026-06-05 | Code: P | equity_swap_involved: 0 | shares_owned_after: 38,915.00 | transaction_form_type: 4 | Footnotes: F2
    • Acquired 3,500 shares of Common Stock at $19.46 per share (Direct)
      Date: 2026-06-05 | Code: P | equity_swap_involved: 0 | shares_owned_after: 42,415.00 | transaction_form_type: 4 | Footnotes: F2
    • Acquired 1,000 shares of Common Stock at $19.27 per share (Direct)
      Date: 2026-06-05 | Code: P | equity_swap_involved: 0 | shares_owned_after: 43,415.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The sales by the reporting person reported herein were matchable under Section 16(b) of the Securities Exchange Act of 1934 with the purchase of 1,000 shares of the Issuer's common stock by the reporting person at the price of $19.27 per share on June 5, 2026. The reporting person has agreed to pay to the Issuer upon settlement of the sale, $155, representing the full amount of the profit realized in connection with the short-swing transaction.
    • F2: The reporting person sold and reacquired the same aggregate number of shares on June 5, 2026.

Search

News categories